Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service
Abstract
Authors
A Toledo I Álvarez-Novoa A Mora C Rubio-Terrés D Rubio-Rodríguez J Nazir